Conti Anna, Scala Simona, D'Agostino Paola, Alimenti Elena, Morelli Daniele, Andria Barbara, Tammaro Angela, Attanasio Chiara, Della Ragione Floriana, Scuderi Vincenzo, Fabbrini Floriana, D'Esposito Maurizio, Di Florio Ernesto, Nitsch Lucio, Calise Fulvio, Faiella Antonio
Department of Biology and Cellular Pathology, Federico II University, Center of Biotechnologies, Naples, Italy.
Liver Transpl. 2007 Jan;13(1):99-113. doi: 10.1002/lt.20960.
Ischemia-reperfusion injury (IRI) causes up to 10% of early liver failures in humans and can lead to a higher incidence of acute and chronic rejection. So far, very few studies have investigated wide gene expression profiles associated with the IRI process. The discovery of novel genes activated by IRI might lead to the identification of potential target genes for the prevention or treatment of the injury. In our study, we compared gene expression levels in reperfused livers (RL group) vs. the basal values before retrieval from the donor (basal liver [BL] group) using oligonucleotide array technology. We examined 10 biopsies from 5 livers, analyzing approximately 33,000 genes represented on the Affymetrix HG-U133APlus 2.0 oligonucleotide arrays (Affymetrix, Santa Clara, CA). About 13,000 individual genes were considered expressed in at least 1 condition. A total of 795 genes whose expression is significantly modified by ischemia-reperfusion in human liver transplantation were identified in this study. Some of them are likely to be completely activated by IRI, as they are not expressed in basal livers. The supervised gene expression analysis revealed that at least 12% of the genes involved in the apoptotic process, 12.5% of the genes involved in inflammatory processes, and 22.5% of the genes encoding for heat shock proteins are differentially expressed in RL samples vs. BL samples. Furthermore, IRI induces the upregulation of some genes' coding for adhesion molecules and integrins. In conclusion, we have identified a relevant amount of early genes regulated in the human liver after 7-9 hours of cold ischemia and 2 hours from reperfusion, many of them not having been described before in this process. Their analyses may help us to better understand the pathophysiology of IRI and to characterize potential target genes for the prevention or treatment of the liver injury in order to increase the number of patients that successfully undergo transplantation.
缺血再灌注损伤(IRI)导致人类高达10%的早期肝衰竭,并可导致急性和慢性排斥反应的发生率更高。到目前为止,很少有研究调查与IRI过程相关的广泛基因表达谱。发现由IRI激活的新基因可能会导致识别出预防或治疗该损伤的潜在靶基因。在我们的研究中,我们使用寡核苷酸阵列技术比较了再灌注肝脏(RL组)与从供体获取前的基础值(基础肝脏[BL]组)中的基因表达水平。我们检查了来自5个肝脏的10份活检样本,分析了Affymetrix HG-U133APlus 2.0寡核苷酸阵列(Affymetrix,加利福尼亚州圣克拉拉)上代表的约33,000个基因。约13,000个个体基因被认为在至少1种情况下表达。本研究共鉴定出795个在人类肝移植中其表达因缺血再灌注而发生显著改变的基因。其中一些基因可能被IRI完全激活,因为它们在基础肝脏中不表达。有监督的基因表达分析显示,与BL样本相比,RL样本中至少12%参与凋亡过程的基因、12.5%参与炎症过程的基因以及22.5%编码热休克蛋白的基因存在差异表达。此外,IRI诱导一些编码黏附分子和整合素的基因上调。总之,我们已经鉴定出在冷缺血7 - 9小时和再灌注2小时后人类肝脏中受调控的相当数量的早期基因,其中许多在此过程中以前未被描述过。对它们的分析可能有助于我们更好地理解IRI的病理生理学,并鉴定出预防或治疗肝损伤的潜在靶基因,以增加成功接受移植的患者数量。